Format

Send to

Choose Destination
Int J Cardiol. 2015;190:126-7. doi: 10.1016/j.ijcard.2015.04.172. Epub 2015 Apr 22.

HDAC inhibition: A novel therapeutic target for attenuating myocardial ischemia and reperfusion injury by reversing cardiac remodeling.

Author information

1
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China.
2
Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Jiefang Road 238, Wuchang, 430060 Wuhan, PR China. Electronic address: jianghongwhu@163.com.

KEYWORDS:

Cardiac remodeling; Histone deacetylases (HDACs); Myocardial ischemia and reperfusion injury

PMID:
25918063
DOI:
10.1016/j.ijcard.2015.04.172
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center